We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.98B
AUM Growth
+$213M
Cap. Flow
+$184M
Cap. Flow %
6.16%
Top 10 Hldgs %
56.07%
Holding
51
New
12
Increased
15
Reduced
12
Closed
11

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$141M
2
JNJ icon
Johnson & Johnson
JNJ
+$90.5M
3
AGN
Allergan plc
AGN
+$84.8M
4
THC icon
Tenet Healthcare
THC
+$76.8M
5
INCY icon
Incyte
INCY
+$75.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$188M
2
BIVV
Bioverativ Inc. Common Stock
BIVV
+$136M
3
EW icon
Edwards Lifesciences
EW
+$98.6M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$86.3M
5
CAH icon
Cardinal Health
CAH
+$84.5M

Sector Composition

Rank Sector Weight
1 Healthcare 78.08%
2 Financials 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$251M 8.42%
+1,000,000
New +$247M
LH icon
2
Labcorp
LH
$25.9B
$237M 7.95%
1,830,146
+229,646
+14% +$30.6M
BIVV
3
DELISTED
Bioverativ Inc. Common Stock
BIVV
$237M 7.94%
4,150,000
-2,325,000
-36% -$136M
ZBH icon
4
Zimmer Biomet
ZBH
$18.4B
$198M 6.64%
1,743,594
+1,220,941
+234% +$141M
AET
5
DELISTED
Aetna Inc
AET
$180M 6.03%
1,131,674
+231,674
+26% +$36.2M
NBIX icon
6
Neurocrine Biosciences
NBIX
$18.7B
$128M 4.29%
2,087,110
-463,068
-18% -$24.4M
MNK
7
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$120M 4.03%
3,214,679
+812,329
+34% +$32.3M
AGN
8
DELISTED
Allergan plc
AGN
$117M 3.94%
573,210
+364,510
+175% +$84.8M
DHR icon
9
Danaher
DHR
$138B
$107M 3.6%
1,412,211
-169,629
-11% -$12.6M
PCRX icon
10
Pacira BioSciences
PCRX
$1.06B
$96.8M 3.24%
2,578,040
+784,241
+44% +$31.6M
JNJ icon
11
Johnson & Johnson
JNJ
$617B
$88.8M 2.98%
+683,050
New +$90.5M
ABBV icon
12
AbbVie
ABBV
$455B
$87.6M 2.94%
986,320
+186,890
+23% +$14.2M
CELG
13
DELISTED
Celgene Corp
CELG
$79.2M 2.65%
543,180
-1,381,820
-72% -$188M
UNH icon
14
UnitedHealth
UNH
$383B
$75M 2.51%
382,990
+279,890
+271% +$54.1M
THC icon
15
Tenet Healthcare
THC
$21.8B
$74.5M 2.5%
+4,531,932
New +$76.8M
INCY icon
16
Incyte
INCY
$24.9B
$69.9M 2.34%
+598,550
New +$75.7M
LIVN icon
17
LivaNova
LIVN
$4.45B
$65.3M 2.19%
931,530
+531,530
+133% +$33.7M
HAE icon
18
Haemonetics
HAE
$3.85B
$65.2M 2.18%
1,452,343
-402,529
-22% -$16.7M
HUM icon
19
Humana
HUM
$44B
$63.6M 2.13%
260,870
+11,772
+5% +$2.88M
SRPT icon
20
Sarepta Therapeutics
SRPT
$1.64B
$54.6M 1.83%
1,202,770
-829,120
-41% -$33.1M
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
$53.3M 1.79%
647,420
+401,120
+163% +$31.8M
VAR
22
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
$50M 1.68%
500,000
+400,000
+400% +$41.1M
SYNH
23
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$48.7M 1.63%
+930,582
New +$51.9M
MRK icon
24
Merck
MRK
$321B
$44.3M 1.48%
+724,461
New +$43.9M
HRC
25
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$43.3M 1.45%
584,770
+459,770
+368% +$35.4M
1
2 3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q3 2017 Portfolio in Review

As of Q3 2017, HealthCor Management held 51 positions worth $2.98B, up 7.7% from $2.77B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

HealthCor Management deployed $184M of net new capital in Q3 2017, opening 12 new positions and adding to 15 existing holdings. Its largest new stake was Johnson & Johnson: 683,050 shares worth $88.8M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 90% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Celgene Corp, an estimated $188M trimmed.

  • HealthCor Management's largest Q3 2017 buy was Johnson & Johnson: 683,050 shares worth $88.8M.
  • HealthCor Management added most to Zimmer Biomet in Q3 2017, an estimated $141M increase.
  • HealthCor Management's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $188M.
  • HealthCor Management fully exited Cardinal Health in Q3 2017, selling an estimated $84.5M.
  • HealthCor Management's ten largest holdings make up 56% of its $2.98B portfolio in Q3 2017.
  • HealthCor Management opened 12 new positions and closed 11 in Q3 2017.
  • HealthCor Management's portfolio value rose 7.7% quarter-over-quarter to $2.98B.

Based on HealthCor Management's 13F filing for Q3 2017, filed 14 Nov 2017.